Literature DB >> 8981914

Induction of neonatal tolerance by plasmid DNA vaccination of mice.

G Mor1, G Yamshchikov, M Sedegah, M Takeno, R Wang, R A Houghten, S Hoffman, D M Klinman.   

Abstract

Plasmid DNA vaccines capable of preventing viral, bacterial, and parasitic infections are currently under development. Our labs have shown that a plasmid DNA vaccine encoding the circumsporozoite protein of the malaria parasite elicits protective immunity against live sporozoite challenge in adult BALB/c mice. We now find that the same DNA vaccine induces tolerance rather than immunity when administered to 2-5 d-old mice. Neonatally tolerized animals were unable to mount antibody, cytokine or cytotoxic responses when rechallenged with DNA vaccine in vitro or in vivo. Tolerance was specific for immunogenic epitopes expressed by the vaccine-encoded, endogenously produced antigen. Mice challenged with exogenous circumsporozoite protein produced antibodies against a different set of epitopes, and were not tolerized. These findings demonstrate important differences in the nature and specificity of the immune response elicited by DNA vaccines versus conventional protein immunogens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981914      PMCID: PMC507733          DOI: 10.1172/JCI119094

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Genetic immunization is a simple method for eliciting an immune response.

Authors:  D C Tang; M DeVit; S A Johnston
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

Review 2.  Cellular mechanisms in neonatal and adult tolerance.

Authors:  B J Roser
Journal:  Immunol Rev       Date:  1989-02       Impact factor: 12.988

3.  Acquisition and maturation of expressed B cell repertoires in normal and autoimmune mice.

Authors:  D M Klinman; Y Ishigatsubo; A D Steinberg
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

Review 4.  Developmental aspects of immunity.

Authors:  J Sterzl; A M Silverstein
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

5.  The interplay of evolution and environment in B-cell diversification.

Authors:  N R Klinman; N H Sigal; E S Metcalf; S K Pierce; P J Gearhart
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

6.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

7.  Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.

Authors:  Y Charoenvit; S Mellouk; C Cole; R Bechara; M F Leef; M Sedegah; L F Yuan; F A Robey; R L Beaudoin; S L Hoffman
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

8.  The ontogeny of antigen-specific T cells.

Authors:  A M Silverstein; S Segal
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

9.  Maturation of the humoral immune response in mice.

Authors:  P G Spear; G M Edelman
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

10.  Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.

Authors:  W R Weiss; S Mellouk; R A Houghten; M Sedegah; S Kumar; M F Good; J A Berzofsky; L H Miller; S L Hoffman
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization.

Authors:  D E Hassett; J Zhang; M Slifka; J L Whitton
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 3.  Plasmid DNA vaccines. Immunology, tolerance, and autoimmunity.

Authors:  G Mor; M Eliza
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

Review 4.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

5.  Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge.

Authors:  D E Hassett; J Zhang; J L Whitton
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences.

Authors:  Z Li; A Howard; C Kelley; G Delogu; F Collins; S Morris
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.

Authors:  C L Brazolot Millan; R Weeratna; A M Krieg; C A Siegrist; H L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 8.  Genetic vaccines--a revolution in vaccinology?

Authors:  Z Q Xiang; S Pasquini; Z He; H Deng; Y Wang; M A Blaszczyk-Thurin; H C Ertl
Journal:  Springer Semin Immunopathol       Date:  1997

9.  DNA immunization of neonates induces immunity despite the presence of maternal antibody.

Authors:  E Manickan; Z Yu; B T Rouse
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

Review 10.  FDA guidance on prophylactic DNA vaccines: analysis and recommendations.

Authors:  Dennis M Klinman; Sven Klaschik; Debra Tross; Hidekazu Shirota; Folkert Steinhagen
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.